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Cranial placodes are embryonic structures essential
for sensory and endocrine organ development.
Human placode development has remained largely
inaccessible despite the serious medical conditions
caused by the dysfunction of placode-derived tis-
sues. Here, we demonstrate the efficient derivation
of cranial placodes from human pluripotent stem
cells. Timed removal of the BMP inhibitor Noggin, a
component of the dual-SMAD inhibition strategy of
neural induction, triggers placode induction at the
expenseofCNS fates.Concomitant inhibitionof fibro-
blast growth factor signaling disrupts placode deri-
vation and induces surface ectoderm. Further fate
specification at the preplacode stage enables the
selective generation of placode-derived trigeminal
ganglia capable of in vivo engraftment, mature lens
fibers, and anterior pituitary hormone-producing cells
that upon transplantationproducehumangrowthhor-
mone and adrenocorticotropic hormone in vivo. Our
results establish a powerful experimental platform to
study human cranial placode development and set
the stage for the development of human cell-based
therapies in sensory and endocrine disease.INTRODUCTION
Cranial placodes give rise to cells of the sensory organs,
including the optic lens, the nasal epithelium, otic structures,
the adenohypophysis, and a subset of cranial nerves such as
the trigeminal ganglia. During development, sensory placodes
are formed at the interface of the nonneural ectoderm and neural
plate, surrounding the anterior portion of the future CNS (Fig-
ure S1A). Defects in placode development cause a wide spec-
trum of human congenital malformations ranging from blindness
and deafness to hormone imbalance or loss of smell (AbdelhakCell Reet al., 1997; Baker and Bronner-Fraser, 2001; Ruf et al., 2004).
To date, cranial placode development has been characterized
in model organisms, including the frog, zebrafish, chicken,
and, to a lesser extent, the mouse (Baker and Bronner-Fraser,
2001; Bhattacharyya and Bronner-Fraser, 2004; Schlosser,
2006). However, human placode development has remained
largely unexplored due to lack of access to early human tissue
and specific placode markers.
Human pluripotent stem cells (hPSCs), including human
embryonic (hESCs), and human induced pluripotent stem cells
(hiPSCs) have the potential to self-renew, while retaining a very
broad differentiation potential. Over the last few years, protocols
have been developed for directing the fate of hESCs into specific
cell lineages. The derivation of CNS cells was among the first
hESC differentiation protocols developed in the field (Reubinoff
et al., 2001; Zhang et al., 2001). The differentiation of hESCs
into cells of the peripheral nervous system has also been
achieved (Lee et al., 2007; Menendez et al., 2011). In contrast
to the successful derivation and application of defined CNS-
and neural-crest (NC)-derived cell types, there has been limited
success on modeling cranial placode development in hPSCs.
Recently, we developed a neural induction strategy based on
the concomitant inhibition of the Bone Morphogenetic Protein
(BMP) and TGF-b/Activin/Nodal signaling pathways (dual-
SMAD inhibition [dSMADi] (Chambers et al., 2009). Exposure
to Noggin (N) and SB431542 (SB) leads to the synchronized,
rapid and efficient differentiation of hPSCs into CNS fates.
Here, we report that derepression of endogenous BMP signaling
during dSMADi is sufficient for the selective induction of human
cranial placodes. Using the placode induction protocol (PIP)
>70% of all cells adopt a SIX1+ cranial placode precursor fate
by day 11 of differentiation. We further identify a preplacodal
lineage competent to differentiate into selective placode fates
including trigeminal sensory neurons, mature lens fibers, and
hormone-producing anterior pituitary cells. Trigeminal sensory
neurons are characterized by marker expression, electrophysi-
ology, and by transplantation into the developing chick embryo
and the adult mouse CNS. Finally, we report the derivation of
human pituitary cells producing growth hormone (GH) and adre-
nocorticotropic hormone (ACTH) hormones in vitro and in vivo.ports 5, 1387–1402, December 12, 2013 ª2013 The Authors 1387
Figure 1. Derivation of Six1+ Placodal Precursors Using a Modified Dual-SMAD Inhibition Protocol
(A) Schematic illustration of timed Noggin withdrawal paradigm to determine temporal requirement for endogenous BMP signaling during placode specification.
The protocol is based on modifying the (N)oggin + (S)B431542 (NSB) protocol developed for CNS induction (Chambers et al., 2009).
(B) Relative induction of placodal markers comparingmodified NSB protocol (various time points of Noggin withdrawal) to N-SB treatmentmaintained throughout
differentiation (NSB condition). Data represent fold changes of mRNA expression measured by qRT-PCR at day 11.
(C) Immunocytochemical analyses of SIX1 and PAX6 expression at day 11 of differentiation. Inset shows a confocal section to demonstrate SIX1 expression
within clusters. Scale bars correspond to 50 mm.
(legend continued on next page)
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RESULTS
Derepression of Endogenous BMP Signaling Induces
Placode at the Expense of Neuroectoderm
To address whether the dSMADi protocol is suitable for the deri-
vation of placodal cells, we first defined a set of appropriate
placode markers. Based on studies in model organisms, we
hypothesized that members of the SIX, EYA, and DLX family
of transcription factors (Baker and Bronner-Fraser, 2001;
Schlosser, 2006) mark human placode fate. Within the ecto-
dermal lineage, SIX1 is placode specific, marking both the early
preplacodal region and the various specific placodes (Schlosser,
2006). Based on studies in the chick embryo, placode induction
relies on a complex interplay of fibroblast growth factor (FGF),
BMP, andWNT signals during early ectodermal patterning in vivo
(Litsiou et al., 2005). Activity of BMPs within the ectoderm is
thought to be particularly critical in allocating fates. A model
has been proposed initially whereby high levels of signaling
promote an epidermal fate, moderate levels induce placodes,
intermediate levels specify NC, and a complete absence of
BMP activity is required for neural plate formation (Wilson
et al., 1997). More recent studies have revised the original model
by confirming an early role for BMP signaling in establishing pla-
code competence (Kwon et al., 2010), whereas the subsequent
stage was shown to require BMP inhibition rather than BMP acti-
vation (Ahrens and Schlosser, 2005; Kwon et al., 2010; Litsiou
et al., 2005).
To test whether early BMP exposure promotes the derivation
of SIX1+ placodal cells, we exposed SB (the TGF-b inhibitor) -
treated hESCs to various concentrations of BMP4. However,
addition of BMP4 in the presence of SB caused a dramatic
morphological change and triggered induction of CDX2 (Figures
S1B and S1C), similar to the BMP-mediated induction of tro-
phectoderm-like lineages reported previously (Xu et al., 2002).
We next tested whether timed withdrawal of the BMP inhibitor
Noggin during Noggin/SB431542 (N-SB)-mediated differentia-
tion could induce placodal fates via derepressing endogenous
BMP signaling. We performed a time-course analysis during
which we removed Noggin at different time points of the N-SB
protocol (Figure 1A). Gene expression analysis at day 11
revealed a robust induction of DLX3, SIX1, and EYA1 (Figure 1B)
upon withdrawal of Noggin at days 2 or 3 of differentiation. In
contrast, Noggin withdrawal at day 1 of differentiation led to
the induction of EYA1 in the absence of SIX1 expression and trig-
gered morphological changes as well as CDX2 expression, sug-
gesting trophectodermal differentiation (though CDX2 and EYA1
can also be expressed in hESC-derived mesodermal lineages
[Bernardo et al., 2011]). Our data indicate that EYA1 is expressed
in both trophectodermal and placodal lineages, and that coex-(D) Quantification of the percentage of Six1+ cells generated under modified N-S
(E) Immunocytochemical analysis of placodal markers EYA1, DACH1, and FOXG
marker. Scale bars correspond to 50 mm.
(F–H) Temporal analysis of gene expression in PIP versus N-SB protocol. Values a
expression of pluripotency (NANOG, OCT4/POU5F1) and trophectodermal (TE)
Induction of placodal fates by monitoring time-course expression of pluripotenc
(SOX17), and placodal markers (DLX3, SIX1, FOXG1).
Error bar represents SD *p < 0.05; **p < 0.01; ***p < 0.001 compared with contro
Cell Repression with SIX1 is required to define placodal lineage. Immu-
nocytochemical analysis of hESC progeny at day 11 of differen-
tiation demonstrated that Noggin withdrawal at day 3 (PIP
conditions) induced a switch from 82% PAX6+ neuroectodermal
cells under N-SB conditions to 71% SIX1+ putative placode pre-
cursor cells under PIP (Figures 1C, 1D, and S1D). SIX1+ clusters
expressed other placodal markers such as EYA1, DACH1, and
FOXG1 (BF1) (Figure 1E). DACH1 is also expressed in anterior
neuroectodermal cells (Elkabetz et al., 2008) marking neural ro-
settes, whereas in PIP-treated cultures DACH1 marks placodal
clusters (Figure S1E). Temporal analysis of gene expression
under PIP conditions revealed rapid downregulation of pluripo-
tency markers (OCT4,NANOG), as well as markers of trophecto-
derm (CDX2) (Figure 1F), mesoderm (T), and endoderm (SOX17)
(Figure 1G). SIX1 expression in placode was confirmed in human
primary tissue (Carnegie Stage 15, 5.5 weeks postconception
[p.c.]; data not shown). SIX1 is also expressed in precursors of
skeletal muscle, thymus, and kidney cells. However, we did
not detect expression of skeletal muscle (MYOD), endoderm
(SOX17), or mesoderm (Brachyury [T]) markers during PIP
confirming that the hESC-derived SIX1+ cells are of placode
identity.We also observed very few (<1%)NC lineage cells under
PIP conditions based on SOX10 expression by immunocyto-
chemistry and SOX10::GFP (Chambers et al., 2012; Mica et al.,
2013) reporter line expression (Figure S1F). Induction of cranial
placode markers was observed by day 5 with FOXG1 preceding
expression of SIX1 and DLX3 (Figure 1H). The PIP protocol
was validated in multiple hESC and hiPSC lines (Figures S1G
and S1H).
To further validate the identity of hESC-derived placodal pre-
cursors, we made use of a conserved Eya1 enhancer element
(Ishihara et al., 2008). We readily observed GFP expression
following nucleofection of the enhancer in olfactory placode
but not in age-matchedmidbrain cultures (Figures S1I–S1J) con-
firming specificity. In hESC-derived placode, we observed an
8-fold increase in the percentage of cells with enhancer activity
in PIP versus N-SB (Figure S1K).
Microarray Analysis Reveals Human Placode Progenitor
Gene Expression
We next performed temporal transcriptome analysis to establish
an unbiased molecular assessment of the in vitro placode induc-
tion process. RNA was collected at five time points in triplicates
(days 1, 3, 5, 7, and 11) in control N-SB- versus PIP-treated cul-
tures (Figures 2A–2E; all raw data are available at GEO accession
no. GSE51533). Prior to microarray analysis, the quality of each
sample was verified for expression of a panel of placodemarkers
(SIX1, DLX3, EYA1) and the absence of other lineage markers
(FOXA2, endoderm; SOX17, endoderm;MYOD, skeletal muscle;B (SB3 = placode induction (PIP) protocol) versus N-SB condition.
1 in placodal clusters. Insets show higher magnification images for respective
re normalized to the expression observed in undifferentiated hESCs. (F) Loss of
markers. (G) Lack of expression of mesodermal and endodermal markers. (H)
y markers (NANOG, OCT4), trophectoderm (CDX2), mesoderm (T), endoderm
l N-SB condition (n = 3 independent experiments). See also Figure S1.
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Figure 2. Temporal Global Gene Expression Profiles during hESC-Derived Placode Specification
(A) Clustering of the differentially regulated genes during PIP versus N-SB protocol.
(B–E) The top 20 most significant up- (red) and downregulated (blue) genes in PIP versus N-SB protocol by fold change at days 5, 7, 9, and 11.
(F and G) Confirmation of ISL1 and TFAP2A expression at the protein level under PIP conditions (day 11).
(H) Confirmation of OVOL2 expression by immunocytochemistry (day 11).
(I) Time-course analysis of OVOL2 gene expression during PIP, N-SB, and NC protocol.
Scale bars in (F)–(H) correspond to 50 mm. See also Figure S2 and Tables S1 and S2.CDX2, trophoblast; and T, mesoderm). Cluster and principal
component analyses showed a temporal segregation of the tran-
scriptome data in PIP versus N-SB-treated cells by day 7 of dif-1390 Cell Reports 5, 1387–1402, December 12, 2013 ª2013 The Autferentiation (Figures 2A and S2A). Transcriptome data also
defined a set of genes that distinguish placodal from neuroecto-
dermal fate (Tables S1 and S2).hors
To gain insight into specific genes differentially expressed dur-
ing placode induction, we performed pairwise comparisons for
each differentiation time point (Figures 2B–2E). Among the
most highly enriched transcripts under PIP condition were
known placode markers such as GATA3, DLX5, DLX3, TFAP2A,
and TFAP2C. SIX1 was significantly upregulated in the microar-
ray analysis by day 9 of differentiation, though it was not among
the 20most differentially regulated genes. Differential expression
for these and additional genes was verified by quantitative RT-
PCR (qRT-PCR) (Figure S2B). We also observed significant tran-
scriptional changes in WNT and BMP pathway components
such as an increase in the WNT pathway inhibitor DKK-1 and
BMP antagonists, such as GREMLIN-1 and BAMBI (Figures
2B–2D), which are known transcriptional targets of BMP
signaling (Grotewold et al., 2001). Interestingly, we also noticed
induction of ISL1, a well-knownmarker for sensory neurons, mo-
toneurons, heart progenitors, and pancreatic islet cells (Hunter
and Rhodes, 2005). Based on the early onset of ISL1 expression
and the absence of mesodermal fates, we surmised that under
PIP conditions ISL1 represents an early human placode marker.
ISL1 was one of the first makers induced during PIP differentia-
tion. Similar to TFAP2A and SIX1 (Figure 2F), ISL1 protein
remained expressed in the majority of cells by day 11 of differen-
tiation partially colocalizing with SIX1 (Figure 2G). Another pla-
code marker identified by our microarray expression data is
OVOL2, a member of the Ovo family of zinc-finger transcription
factors. OVOL2 was enriched during PIP by day 5 of differentia-
tion, and placode clusters showed strong immunoreactivity for
OVOL2 (Figure 2H). In contrast, OVOL2 was downregulated un-
der conditions promoting CNS (N-SB) or neural crest (N-SB/
CHIR [Chambers et al., 2012; Mica et al., 2013]) fates (Figure 2I).
We identified additional differentially expressed genes during
anterior placode specification, including FOXC1 and HAPNL1
(also known as CRTL1). FOXC1 marks the lens placode during
chick development (Bailey et al., 2006) but may also be ex-
pressed at the preplacode stage (Sasaki and Hogan, 1993).
HAPNL1 was one of the most differentially expressed genes in
PIP and was previously shown to be expressed in the surface
ectoderm and chick neural plate border (Colas and Schoenwolf,
2003). Gene ontology (GO) analysis, using DAVID (http://david.
abcc.ncifcrf.gov/) (Dennis et al., 2003), indicated that transcripts
highly enriched in PIP versus N-SB conditions at day 7 and day
9 of differentiation are associated with sensory organ develop-
ment, BMP and WNT pathways, as well as ectoderm and
epidermis development (Figure S2C). The total number of differ-
entially expressed genes increased by day 7 of differentiation
(Figures S2D and S2E) matching the proposed time frame for
placode commitment. In summary, our molecular analyses pre-
sent a roadmap of human placode development and an impor-
tant resource for future functional studies.
Early Treatment with FGF Inhibitor Suppresses Placode
and Induces Surface Ectoderm Fate
Lineage studies in several vertebrate species indicate that cra-
nial placode precursors originate from the surface ectoderm
and are induced by signals emanating from the adjacent neuro-
ectoderm (Pieper et al., 2012), rather than being of neural origin.
However, no such data are available for human development.Cell ReThe putative timing of human placode induction (approximately
day 20 p.c.) (O’Rahilly, 1987) makes this a stage largely inacces-
sible to experimental manipulations. Gene expression data dur-
ing PIP indicate that TFAP2A is one of the earliest upregulated
and differentially expressed genes (Figures 2B–2E). During
mouse development, early expression of the orthologous gene
Tcfap2a (E7.5) is restricted to the future surface ectoderm (Arkell
and Beddington, 1997).
The induction of TFAP2A was first detected at day 5 of PIP,
whereas absent in N-SB protocol (Figure 3A) suggesting that
the period between days 3 and 5 of PIP corresponds to the
commitment toward surface ectoderm. SIX1 was induced
2 days later than TFAP2A (Figures 3A and 3B) further pointing
to a surface ectoderm intermediate. In vivo genetic studies indi-
cate that high levels of BMPs in the absence of FGF signaling
promote epidermal fate, whereas placodal cells are established
at reduced levels of BMPs upon activation of FGFs (Kudoh et al.,
2004; Litsiou et al., 2005). Therefore, we tested whether blocking
endogenous FGF signaling under PIP conditions disrupts
placode induction and triggers epidermal fate. Exposure to
SU5402, a small molecule inhibiting FGF signaling, from day 3
to 11 of differentiation (Figure S3A) suppressed the emergence
of SIX1+ clusters while maintaining TFAP2A expression (Fig-
ure 3C). Quantification of SIX1 and TFAP2A gene expression at
day 11 confirmed a complete loss of placode marker expression
(Figure 3D), whereas TFAP2A expression was maintained. The
ectodermal precursor identity of TFAP2A+ cells was supported
by the expression of the epidermal precursor marker KRT8 in
PIP + SU5402-treated cultures (Figure 3E). Furthermore, long-
term cultures (days 42–60) showed robust induction of the
mature keratinocyte marker KRT14 (Figure 3F) and formed
E-CADHERIN-positive patches with KRT14-immunoreactive
cells at the periphery (Figure S3B). Analysis of the proliferative
capacity of the epidermal precursors showed KI67 expression
primarily in E-CADHERIN+/KRT14 cells. Cell proliferation
decreased by day 60 concomitant with an increased percentage
of cells expressing KRT14 (Figures 3G and S3C). In addition to
the requirement for endogenous FGF signaling, we observed
low WNT and BMP levels as other important parameters for
the transition from surface ectoderm (day3) to early placode
fate. Exposure to high concentrations of CHIR or BMP4 sup-
pressed placode at the expense of NC or putative trophecto-
derm, respectively (Figures S3D and S3E).
Placode Precursors Efficiently Differentiate into
Trigeminal-type Sensory Neurons
Cranial placodes give rise to a broad range of specialized cell
types, including hormone-producing cells of the anterior pituitary
gland, structural cells such as lens fibers in the eye, and sensory
neurons including trigeminal neurons (Figure 4A). Placodes can
be characterized by the expression of specific PAX genes
(McCauley and Bronner-Fraser, 2002). We observed that under
standard PIP conditions most SIX1+ clusters coexpressed
PAX3 (Figure 4B), suggesting ophthalmic trigeminal placode
identity (McCabe et al., 2004; Stark et al., 1997). The sponta-
neous generation of HNK1+ (Metcalfe et al., 1990) cells with
neuronal morphologies and coexpression of ISL1 confirmed pe-
ripheral sensory neuron identity (Figure 4C). To further ascertainports 5, 1387–1402, December 12, 2013 ª2013 The Authors 1391
Figure 3. FGF Signaling Determines Placodal versus Nonneural Ectoderm/Epidermal Fate
(A and B) Time course of the induction of TFAP2A and SIX1 under PIP conditions.
(C) TFAP2A (green) is expressed in placodes and surface ectoderm, whereas SIX1 (red) is only expressed in placode cells. Blocking PIP via pharmacological
inhibition of endogenous FGF signaling blocks the formation of SIX1+ cells.
(D) Quantification of the loss of SIX1 gene expression following treatment with the FGF inhibitor SU5402.
(E) Expression of early epidermal marker KRT8. Data represent fold changes of mRNA expression by qRT-PCR at day 11 compared to PIP condition.
(F) Expression of late epidermal marker KRT14 during keratinocyte differentiation. Data represent fold changes of mRNA expression by qRT-PCR at day 11 and
day 42 compared to hESC.
(G) Long-term SU5402-treated cultures are expressing KRT 14 protein suggesting epidermal/keratinocyte fate.
Error bar represents SD *p < 0.05; **p < 0.01; ***p < 0.001 compared with control PIP condition (n = 3 independent experiments). Scale bars in (C) and (G)
correspond to 50 mm. See also Figure S3.the placode origin of the sensory neurons under PIP conditions,
we assessed coexpression of neuronal markers with SIX1 (Fig-
ures 4D and S4A). Lack of SOX10 expression during PIP-based
sensory neuron differentiation ruled out a neural crest origin. By
day 20 of differentiation (7 days after replating), the cells formed
ganglia-like structures with neurons extending long, radial pro-
cesses and with nuclear expression of BRN3A (Figures 4D
and 4E), a sensory neuron marker. Most neurons retained ISL11392 Cell Reports 5, 1387–1402, December 12, 2013 ª2013 The Autexpression by day 42 of differentiation and acquired expression
of the peripheral neuron marker peripherin (Figures 4F and S4B).
Immunocytochemical analysis for neurotransmitter phenotypes
revealed expression of glutamate (Figure 4G) but lack of expres-
sion of TH and GABA (data not shown). These data are compat-
ible with the generation of glutamatergic trigeminal sensory
neurons. Gene expression analysis showed induction of
RUNX1 (Figures 4H and S4C) and RET (Figure S4D), indicatinghors
sensory/nociceptive lineage. Expression of TRK receptors (Fig-
ures 4I and S4E) includingNTRK1 andNTRK2 points to the pres-
ence of both nociceptive and nonnociceptive sensory neurons
(Figures S4E–S4G). Diagnostic markers of nociceptive neuron
identity include expression of specific sodium channels
(SCN9A, SCN10A, SCN11A; Figure 4J) as well as classic pain
receptors such as the capsaicin receptor (TRPV1), the receptor
for cold sensation (TRPM8), and the P2X3 receptor critical for
sensation of inflammatory pain mediated by ATP (Figure 4K).
Gene expression analysis in long-term trigeminal neuronal
cultures (day 55) showed sustained expression of RET1 and
RUNX1 (Figures S4C and S4D).
Functional analysis of placode-derived sensory neurons was
performed by whole-cell patch-clamp recordings (Figure S4G).
Neuronswere filledwith Lucifer yellow from the recording pipette
exhibiting either bipolar or tripolar morphologies (Figures 4L and
4M). Responses were measured to a series of hyperpolarizing
and depolarizing pulses (Figure 4N). The hESC-derived neurons
produced single action potentials at a threshold depolarization
matching the functional properties reported for primary embry-
onic trigeminal neurons (Grigaliunas et al., 2002). The average
resting membrane potential (RMP) was 65.6 ± 6.7 (Figures 4L
and 4M). Passive membrane and action potential properties
were comparable between bipolar and tripolar sensory neurons
as summarized in (Figure 4O) suggesting that two morphologi-
cally distinct populations do not reflect functionally distinct sub-
groups. We further assessed the robustness of the trigeminal
sensory neuron induction protocol across multiple hESC and
hiPSC lines. We observed comparable percentages of ISL1-
and BRN3A-expressing neurons across lines (Figure S4H).
In Vivo Analysis of hESC-Derived Trigeminal Neurons in
the Developing Chick Embryo and Adult Mouse CNS
To assess the in vivo properties of hESC-derived trigeminal pla-
code precursors, PIP-induced neuronal clusters, derived from a
constitutively GFP-positive hESC line (Figures S5A and S5B),
were injected into the developing chick embryo targeting the
early trigeminal anlage at H&H stage 10–12 (Figure S5C). Human
cells were identified based on GFP expression and use of human
specific antibodies against cytoplasmic antigen (hCA). Two days
after in ovo transplantation, surviving GFP+ cells were found
dispersed in the area of the endogenous chick trigeminal gan-
glion (Figure 4P). We observed extensive GFP+ human fiber bun-
dles coexpressing hCA and peripherin (Figures 4Q and 4R). In
contrast, no hCA or peripherin expression was detected in the
neural tube of the embryo (Figure S5D). The in vivo fiber
outgrowth 2 days after transplantation was reminiscent of the
extensive in vitro fiber outgrowth of replated trigeminal neuron
clusters (Figure S5A). Peripherin expression in vivo (Figure 4S)
confirmed the peripheral neuron identity of the grafted cells.
We next addressed whether hESC-derived trigeminal neurons
can engraft in the adult mouse CNS and project toward their
physiological target. The trigeminal nuclei in the brainstem
receive afferent innervation from the trigeminal sensory ganglion
that is relayed to the contralateral thalamus. The pons was
selected as site for transplantation, because it is surgically
accessible and located within proximity of the trigeminal brain
stem nuclei that receive afferent input from the trigeminalCell Reganglia. Hence, GFP+ human trigeminal neuron clusters were
injected into adult NOD/SCID mice via stereotactic surgery
(see Experimental Procedures). Histological analysis 4 weeks
after transplantation showed survival of GFP+ human cell graft
in the ventral pons (Figure S5E). Although GFP+ cell bodies re-
mained tightly clustered at injection site, GFP+ fibers showed
extensive projections into the host brain (n = 6) including the
endogenous trigeminal nuclei (Figure S5F). Expression of
BRN3A confirmed the sensory neuron identity of the cells (Fig-
ure S5G). Graft-derived human fiber bundles (hNCAM+ and
GFP+)were observed emanating from the graft core (FigureS5H).
These data demonstrate in vivo survival of trigeminal placode
derivatives, differentiation along sensory neuron lineage, and
the establishment of axonal projections toward relevant endog-
enous targets in the embryonic chick and adult mouse brain.
Identification of a Putative Preplacode Stage
Our results indicate that current PIP conditions efficiently induce
ophthalmic trigeminal placode fates. To investigate whether
other placodal fates can be generated using modified PIP condi-
tions, we first addressed the presence of putative preplacode
cells in our culture system. During vertebrate development, the
preplacode is characterized as the developmental anlage con-
taining precursor cells competent to respond to signals deter-
mining placode identity (Martin and Groves, 2006). Preplacodal
cells in various model organisms have been shown to express
Six1 and to coexpress markers of both ectodermal and neural
fate. However, the development of a human preplacode remains
unexplored. We performed a time-course coexpression analysis
for TFAP2A (early ectodermal marker) and PAX6 (early neuroec-
toderm marker [Zhang et al., 2010]). During the first 3 days of
differentiation, only a few sparse patches of PAX6- or TFAP2A-
expressing cells were observed without evidence of coexpres-
sion (Figure 5A). At day 5, 2 days following Noggin withdrawal
(PIP), there was an increase in the number of TFAP2A+ cells (Fig-
ure 5B) under PIP conditions and a concomitant loss of TFAP2A+
cells in N-SB (Figure 5C). At day 7, N-SB conditions yielded
PAX6+ cells devoid of TFAP2A expression (Figure 5C), whereas
PIP-treated cultures showed extensive coexpression of TFAP2A
and PAX6, indicating preplacode identity (Figure 5B). The emer-
gence of TFAP2A/PAX6 double-positive cells coincided with the
onset of SIX1 gene expression and the emergence of SIX1+ clus-
ters around day 7 of differentiation (Figures 3B and S6A). By day
11, placode clusters were negative for PAX6 but retained
expression of TFAP2A (Figure 5B), suggesting that early anterior
PAX6+ preplacode cells give rise to PAX6-negative posterior pla-
code populations enriched for PAX3+. This model was further
supported by gene expression data showing a robust PAX3 in-
crease from day 7 to 11 of PIP (Figure 5D). Treatment with inhib-
itors ofWNT or FGF signaling from day 7 to 11 of PIP suppressed
PAX3 induction (Figure 5E) while maintaining PAX6 (Figure 5F).
Our results indicate that endogenous signals contribute to the
transition from an anterior PAX6+ preplacode to a posterior
PAX3+ placode lineage. The small number of TFAP2A cells in
day 11 N-SB cultures (Figure 5C) likely represents neural crest
precursors (Chambers et al., 2009) that lack PAX6 expression.
Under PIP conditions the percentage of contaminating SOX10+
NC cells at day 11 was <1% (Figure S1F).ports 5, 1387–1402, December 12, 2013 ª2013 The Authors 1393
(legend on next page)
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Treatment with FGF Inhibitor SU5402 at Preplacode
Stage Induces Lens Fates
Wenext testedwhether putative preplacode cells can be coaxed
into specific placode fates other then trigeminal neurons. The
spontaneous appearance of lens precursors (lentoid bodies)
from primate and hESCs has been previously reported (Ooto
et al., 2003; Zhang et al., 2010), although the lineage origin and
inducing signals remained unexplored in those studies.
We tested the impact of four developmental signaling path-
ways on lens placode specification using activators and inhibi-
tors of BMP, FGF, WNT, and Hedgehog signaling. To quantify
the induction of lens placode fate, we monitored expression of
the lens precursor marker PITX3 at day 16 of differentiation
(Figure S6B). PITX3 expression was significantly induced in the
presence of recombinant BMP4 or upon exposure to the FGF-
inhibitory molecule, SU5402 (Figure 5G). A role for BMPs and
FGFs has been previously proposed in developmental studies
in the chick (Sjo¨dal et al., 2007). Further differentiation revealed
strong induction of ab-crystalline and the formation of mature
lens fiber structures by day 57 (Figure 5H, left panel). The char-
acteristic layering of lens fibers (Figure 5H, right panel) mimicked
the structural properties of developing lens in vivo.
Treatment with SHH at Preplacode Stage Induces
Anterior Pituitary Cells
We next explored whether preplacodal cells can be differenti-
ated into anterior pituitary placode and recreate the various pitu-
itary precursors and hormone-producing cell types (Figure 6A).
We observed that treatment with agonists for SHH signaling (Fig-
ure S7A) at the preplacode stage (days 7–11) induced expres-
sion of the oral ectoderm marker SIX6 and PITX1 (Figure 6B),
master regulators of pituitary gland development (Tremblay
et al., 1998). Induction of PITX1 and SIX6 at transcript and pro-
tein levels was dependent on SHH dose (Figures 6B and 6C).
Furthermore, SHH treatment triggered the expression of the
definitive pituitary precursor marker LHX3 (Figure 6D).Figure 4. Derivation, Characterization, and Transplantation of hESC-D
(A) Schematic representation of various placodes derived during development
structural cells such as lens fibers (lens placode), and sensory neurons (trigeminal
under PIP conditions.
(B) PAX3, a trigeminal placode marker, is expressed in SIX1+ placode clusters a
(C) Placode clusters by default rapidly yield cells expressing sensory neuron ma
(D) Immunocytochemical analysis at day 20 of differentiation demonstrates that S
that initially retain SIX1 expression.
(E) Sensory neuron identity is further confirmed by expression of BRN3A in the m
(F) At day 42 of differentiation, neurons show increased expression of peripherin
peripheral neuron fate.
(G) Trigeminal neurons stain for glutamate.
(H–K) (H) Expression of RUNX factors, (I) TRK receptors, (J and K) nociceptor-spe
and cold (TRPM8) sensation and for inflammatory pain (P2X3; n = 3 independen
(L and M) Examples of single cell patch clamp electrophysiological analysis in hE
(N) The intensity of the stimulus was started from125 pA and increased by 25 pA
increments.
(O) Summary of quantitative electrophysiological parameters showed comparab
(P–S) Transplantation into trigeminal anlage in chick embryo. (P) GFP-labeled c
shows GFP+ fiber bundles: GFP (green) and DAPI (blue). Insert, section at midbra
fiber bundles express human cytoplasmic marker (green) and the sensory neuron
ganglia-like clusters in vivo.
All scale bars correspond to 50 mm. See also Figures S4 and S5.
Cell ReEndocrine cells of the anterior pituitary gland are derived from
three main precursors lineages (Scully and Rosenfeld, 2002).
Following PIP + SHH treatment, we observed robust induction
of TBX19 (Figure 6E), specific to precursors giving rise to
ACTH- and MSH-producing cells. Induction of PIT1 and
GATA2 precursor lineages was less efficient but was increased
following treatment with the g-secretase inhibitor DAPT (Figures
6F and 6G). Immunocytochemistry for pituitary hormones
showed expression of CGA by 16 days, whereas protein expres-
sion of FSH, ACTH, and GH was first observed by days 25–30 of
differentiation (Figures 6H–6K). The induction of ACTH+ cells was
particularly efficient (Figure 6J), and in vitro release of ACTH hor-
mone could readily be detected by ELISA (Figure 6L).
We next tested whether hESC-derived pituitary cells are
capable of in vivo survival and function in mouse and rat xeno-
graft models (Figures 6M, S7B, and S7C). Subcutaneous injec-
tion of GFP-marked, hESC-derived pituitary precursors (day 16
of differentiation) into adult male NOD/SCID mice demonstrated
survival of glycoprotein subunit (GSU) and follicle-stimulating
hormone (FSH) cells in vivo (Figures S7D and S7E). Longer-
term survival studies in nude male rats (n = 8; 4–6 weeks post-
grafting) showed significant increases in serum ACTH levels
(Figure 6N) as measured during early morning hours (low point
of endogenous ACTH expression during diurnal cycle). We also
measured levels of human GH in vivo using an ELISA assay
that selectively detects human but not mouse GH (Figure 6O).
Transplantation into rat hosts allowed for repeated blood draws
and showed a consistent increase of ACTH and GH levels in
grafted as compared to sham injected (Matrigel-only) animals.
Finally, histological analysis demonstrated in average 0.46 ±
0.015 million surviving hNCAM+ cells (Figure 6P) at 6 weeks after
transplantation. About 10% of the surviving human cells ex-
pressed ACTH (Figure 6Q) and 6% of the cells were immunore-
active for GH (Figure 6R). The ability to derive functional
hormone-producing pituitary cells from hESCs via modified
PIP conditions is particularly intriguing given previous work inerived Trigeminal-type Sensory Neurons
for preplacode cells including hormone-producing cells (pituitary placode),
placode). Trigeminal placode fate (highlighted in orange) appears to be a default
t the placode stage at day 11.
kers such as ISL1 and HNK1.
IX1+ placodal clusters efficiently yield large numbers of TUJ1-positive neurons
ajority of neurons derived from SIX1+ clusters.
and decreased levels of TUJ1 staining suggesting adoption of a more mature
cific channels and receptors in trigeminal neurons responsible for hot (TRPV1)
t experiments; error bars represent SEM).
SC-derived trigeminal-type neurons at day 53 of differentiation.
until a single action potential was observed. Steps shown correspond to 25 pA
le patterns for both bipolar and tripolar type neurons.
ells and graft morphology 2 days after transplantation. (Q) Low-power image
in level shows GFP+ fiber bundles adjacent to trigeminal anlage. (R) The human
marker, peripherin (red). (S) GFP+/PERIPHERIN+ cells bodies are arranged in
ports 5, 1387–1402, December 12, 2013 ª2013 The Authors 1395
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mouse ESCs suggesting the need for complex coculture sys-
tems to induce pituitary lineages (Suga et al., 2011). In vivo sur-
vival and production of graft-derived ACTH and GH suggest
translational potential for patients suffering from genetic, surgi-
cal, or radiation induced hypopituitarism (Tabar, 2011).
DISCUSSION
An Experimental Platform for the Efficient Generation of
Human Cranial Placodes In Vitro
The study of human cranial placode development has been chal-
lenging due to the lack of a tractable experimental system, the
inaccessibility of this transient structure during early human
development, and the absence of validated human placode
markers. Our data resolve those major challenges and establish
a versatile platform for the study of human placode and ecto-
derm development (Figure 7). Previous studies have observed
the emergence of certain placode derivatives such as lens
(Ooto et al., 2003; Zhang et al., 2010) or otic placode-derived
cells (Chen et al., 2012; Oshima et al., 2010). However, themech-
anisms of placode induction were not addressed, and no general
model of placode specification has emerged from those studies.
Very recent studies have shown some promise in directing
pluripotent stem cells toward placode fates (Leung et al., 2013;
Mengarelli and Barberi, 2013; Shi et al., 2007). However, no func-
tional human placode derivatives have been reported under
those conditions. In contrast, studies in mouse ESCs have suc-
cessfully derived functional otic (Koehler et al., 2013) and pitui-
tary (Suga et al., 2011) placode derivatives.
A developmental question of particular interest is the origin of
placode cells. The prevalent hypothesis is that placode tissue
originates from nonneural ectoderm upon response to inductive
signals from the adjacent neural tissue (Schlosser, 2006). Our
data indicate that human placode development similarly origi-
nates from nonneural ectoderm based on the result that TFAP2A
expression precedes the induction of SIX1, whereas TFAP2A
is suppressed during N-SB induction. BMP-based induction of
TFAP2A and GATA3 may be critical in establishing nonneural
ectoderm lineage competent for placode induction (Kwon
et al., 2010). The ability to block placode induction at the
expense of nonneural ectoderm by inhibition of FGF signaling
further supports a nonneural ectoderm origin and suggests
that endogenous FGF signals may be the neural signal respon-
sible for the placode default in PIP. Our findings further delineate
the time point of developmental commitment to placodal fate byFigure 5. Identification of Putative Preplacode and Directed Differentia
(A) Immunocytochemical analysis for TFAP2A and PAX6 at day 3 of differentiatio
(B) Time-course analysis at days 5, 7, 9, and 11 of PIP differentiation show coex
(C) Time-course analysis at days 5, 7, 9, and 11 of N-SB differentiation shows lack
(D) Temporal analysis of PAX3 gene expression during PIP versus NSB protocol
(E) PAX3 expression levels following treatment (days 7–11) with activators or
during PIP.
(F) PAX6 expression levels using same treatment as in (E).
(G) Results of a four signaling pathway screen (modulators of BMP, FGF, WNT,
marker PITX3 by qRT-PCR was observed upon treatment with activators of BMP
(H) Modified placode cultures differentiating into Crystalline+ cells with mature le
Scale bars in (A)–(C) correspond to 25 mm. Scale bars in (H) correspond to 50 mm. E
PIP condition (n = 3 independent experiments). See also Figure S6.
Cell Reday 7, given that treatment of cells at day 7 of differentiation
(preplacode) induced a switch between various placode fates
but did not affect the ratio of cells of placode versus nonneural
ectoderm fate.
Previous work described FOXG1 and DACH1 as markers of
anterior neuroectoderm and neural rosette stage cells during
hPSC differentiation (Chambers et al., 2009; Elkabetz et al.,
2008). Our study reports a small percentage of SIX1+ cells that
emerge spontaneously under N-SB conditions. Therefore, differ-
entiation studies aimed at generating CNS lineages should
address whether contaminating placodal tissues are present in
hPSC-derived neural cultures. Those spontaneously emerging
placodal cells are likely the source of lentoid bodies and other
placode derivatives observed in past neural differentiation
studies. Our gene expression data define a broad set of placode
markers valuable for future studies. For example, OVOL2 has
been shown to be expressed in the mouse epiblast and surface
ectoderm, and loss of Ovol2 leads to early embryonic lethality
(Mackay et al., 2006). Here, we define OVOL2 as a human pre-
placode marker. FOXC1 and ISL1 are additional transcription
factors specifically expressed at the preplacode stage. Our
data provide a framework for defining transcriptional networks
that distinguish cranial placode identity from early CNS, neural
crest, and surface ectoderm identity.
Specification toward Functional hESC-Derived Placode
Derivatives
The current study defines a transient preplacode population
competent to adopt various specific placode identities. The
emergence of a preplacodal region has been described during
Xenopus and zebrafish development (Bailey et al., 2006; Martin
and Groves, 2006; Schlosser, 2006). Our data indicate that PIP
initially yields a PAX6+/SIX1+ anterior preplacode population
that spontaneously adopts a more posterior, PAX3+ ophthalmic
trigeminal fate upon further differentiation, likely due to the caud-
alizing effects of endogenous FGF andWNT signals. Exposure to
SHH or suppression of FGF signaling at day 7 of differentiation
directs the putative preplacode precursors into anterior pituitary
and lens placodes fates. Lens placode has been suggested as
the default state during chick placode development with FGF8
being necessary and sufficient to specify olfactory placode
fate (Bailey et al., 2006). Elegant studies in mouse ESCs (Koehler
et al., 2013; Suga et al., 2011) have shown the feasibility of gener-
ating hormone-producing pituitary cells and otic sensory neu-
rons respectively using sophisticated 3D culture systems. Ourtion toward Human Lens Placode Lineage
n.
pression of TFAP2A and PAX6 at days 7 and 9 of differentiation.
of TFAP2A expression but expression of PAX6 in CNS neuroectodermal cells.
.
inhibitor of FGF (FGF8, SU5402) and WNT signaling (CHIR99021, XAV939)
and SHH signaling added at days 7–11 of PIP). Induction of the lens placode
signaling (BMP4) or inhibitors of FGF signaling (SU5402).
ns fiber morphologies by day 57 of differentiation.
rror bar represents SD. *p < 0.05; **p < 0.01; ***p < 0.001 comparedwith control
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Figure 7. Proposed Model for the Derivation of Human Placodes from hPSCs
Placode induction is dependent on derepression of BMP signaling using dSMADi protocol. Continuous BMP repression induced CNS fates; derepression of BMP
in combination with the inhibition of FGF signaling by SU5402 triggers epidermal fates. Preplacodal cells can be further patterned toward specific placode fates
by modulating FGF, BMP, or SHH signaling at day 7 of differentiation leading to functional lens, trigeminal neuron, and anterior pituitary derivatives.results demonstrate that modified PIP conditions yield human
pituitary precursors efficiently without the need for complex 3D
culture conditions. Although we observe a bias in generating
preferentially TBX19-related pituitary lineages including ACTH-
producing cells, all three major precursor lineages (GATA-2,
TBX19, and PIT1 lineages, Figure 6A) could be derived. There-
fore, it is likely that further optimization of the protocol will pro-
vide selective access to individual pituitary hormone lineages.
Our current in vivo studies are limited to amaximum engraftment
period of 3 months, subcutaneous injections into the flank of
adult murine hosts, and use of animals (both mouse and rat)
with normal pituitary function. Future experiments should include
longer-term survival studies and an in-depth analysis of graft
integration into the hypothalamic-pituitary axis, possibly viaFigure 6. Specification and Functional Characterization of Hormone-P
(A) Schematic illustration of normal pituitary lineage development in vivo (Tabar, 2
are listed in bold (ACTH, GH, FSH).
(B) Treatment with SHH from days 7 to 11 of PIP differentiation induced PITX1 and
anlage. Low SHH: 20 ng/ml C25II SHH; high SHH: 100 ng/ml C25II SHH + 1 mM
(C) Immunocytochemical analysis showed expression of SIX6 at the protein leve
(D) Immunocytochemical analysis for expression of LHX3 at day 16 (upon SHH t
(E–G) Induction of defined endocrine precursor lineages: (E) TBX19 expression w
entiation (see Figure S7A for treatment paradigm). (G) GATA2 expression at day
(H–L) Immunocytochemical evidence of hormone production (H) CGA expressi
expressed by day 27. (J) ACTH expression was most abundant in SHH-treated
entiation. (L) ELISA measurement of in vitro hormone production after 10 min ex
(M) Schematic illustration of transplantation paradigm in nude rat host.
(N) ACTH plasma levels in grafted adult nude rats and sham-grafted controls at
(O) GH plasma levels using a human specific ELISA (6 weeks after transplantatio
(P–R) Histological analysis 6 weeks after transplantation: (P) Robust survival of hN
Scale bars are 100 mm in (C) and (P); 50 mm in (D), (H)–(J), and (Q)–(S); and 10 mm in
controls PIP condition in (B), hESC in (E)–(G); n = 3 independent experiments), HB
animals in (N) and (O) (n = 3 and n = 5 animals). See also Figure S7.
Cell Reorthotopic graft placement into the hypothalamus or the sella.
Finally, in vivo hormone function will need to be validated in
animal models of pituitary dysfunction.
We present data on the specification of trigeminal, lens, and
anterior pituitary placode lineages. However, preliminary evi-
dence indicates that other placode fates are accessible as well
using modified PIP conditions. For example, exposure of prepla-
code cells to FGF8 enriches for ASCL1 expression compatible
with olfactory placode fate (Balmer and LaMantia, 2005). Expo-
sure to caudalizing cues such asWNT3A leads to the induction of
a population of cells coexpressing SIX1 and SOX10 compatible
of otic placode fates. Those conditions, although requiring
further optimization, support the notion that PIP represents a
universal platform for cranial placode fate specification.roducing Pituitary Placode Derivatives
011). Examples of hormone-producing cells generated using our modified PIP
SIX6 expression as assessed by qRT-PCR. PITX1 and SIX6mark the pituitary
purmorphamine.
l in a subset of clusters in the presence of SHH treatment.
reatment).
as highly induced by day 20. (F) PIT1 expression at days 20 and 32 of differ-
s 20 and 32 of differentiation.
on was readily detected by day 16 in SHH-treated PIP cultures. (I) FSH was
PIP culture by day 30 of differentiation. (K) GH expression at day 30 of differ-
posure in HBSS.
4 and 6 weeks after transplantation.
n).
CAM+ human cells. (Q) ACTH-expressing and (R) GH-expressing cells in vivo.
(K). Error bar represents SEM. *p < 0.05; **p < 0.01; ***p < 0.001 compared with
SS without cells in (L), and plasma samples fromMatrigel-only injected (Sham)
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One of the most immediate applications of PIP-based differ-
entiation is the derivation of trigeminal sensory neurons. Given
our recent success in deriving neural-crest-derived nociceptive
neurons (Chambers et al., 2012), it will be intriguing to compare
the developmental and functional features of neural crest versus
placode-derived nociceptors. Trigeminal neurons are involved
in several pain syndromes such as trigeminal nerve palsy, tri-
geminal neuralgia, and migraine pain (Love and Coakham,
2001). Therefore, the ability to generate large numbers of tri-
geminal neurons will be particularly useful for modeling human
nociception and for the development of cell-based drug screens
in pain research. Another important application will be modeling
Herpes simplex encephalitis using human iPSCs (Lafaille et al.,
2012). HSV-1 is a virus that specifically persists in a latent
form within the trigeminal ganglia (Barnett et al., 1994). The abil-
ity to derive trigeminal neurons from patient-specific iPSCs
should address whether defects in the control of viral latency
contributes to Herpes simplex encephalitis. The robust in vivo
survival of trigeminal placode precursors raises the possibility
for developing future regenerative approaches with the goal of
nerve repair following mechanical, radiation, or chemotherapy-
induced damage. Finally, the potentially largest impact on
regenerative medicine may come from deriving functional
hormone-producing cells. Hypopituitarism is a common conse-
quence of congenital defects, head injury, or therapeutic inter-
vention in patients with pituitary tumors or patients receiving ra-
diation therapy (Tabar, 2011). Although replacement hormones
can be given to normalize resting serum levels in patients, the
financial, logistic, and medical costs for such lifelong treatments
are considerable. Furthermore, hormone replacement therapy
does not allow for dynamic release in response to circadian
rhythms, or rapid adjustments to physiological changes in the
environment or stressful challenges. Therefore, the ability to
generate large numbers of functional ACTH- and GH-producing
cells launches the possibility of long-term therapeutic cell




hESCs (WA-09; passages 35-45), hiPSC lines (iPS-14, iPS-27; passages 20–
30), and I6 were maintained at undifferentiated state and differentiated toward
CNS lineages using dual-SMAD inhibition protocol described previously. For
PIP, Noggin was removed at day 3 of differentiation. In some experiments,
BMP-4, Noggin, DKK-1, FGF8, SU5402, Wnt-3a, DAPT, CHIR99021, cyclop-
amine, Sonic Hedgehog (SHH), and purmorphamine were added as detailed
in the Supplemental Experimental Procedures. For differentiation toward tri-
geminal sensory fate placode clusters were maintained in N2 medium supple-
mented with ascorbic acid and BDNF. Pituitary fate was induced by exposure
to SHH and purmorphamine from day 7 to 11 of PIP followed by treatment with
DAPT to promote PIT1+ fate.
Cell Characterization
qRT-PCRdata were normalized to HPRT and are based on four to six technical
replicates from at least three independent experiments. Global gene expres-
sion analysis was performed by the MSKCC genomics core according to the
specification of the manufacturer (Illumina Human-6 oligonucleotide arrays).
Detailed information on the use of primary antibodies for immunocytochem-
istry and flow analysis and on the electrophysiological analyses is presented
in the Supplemental Experimental Procedures.1400 Cell Reports 5, 1387–1402, December 12, 2013 ª2013 The AutAnimal Studies
Animal studies were done in accordance with protocols approved by our
institutional Animal Care and Use Committee and following NIH guidelines.
Hormone-producing cells were injected subcutaneously into adult male
NOD-SCID IL2Rgc mice and eight adult male nude rats. Blood was collected
at 4–6 weeks after the transplantation followed by ELISA analysis for deter-
mining hormone levels. Chick transplantation studies were performed at HH
stage 9–10, and embryos were harvested at HH stage 20. Injections into
pons of adult NOD-SCID IL2Rgc mice were performed by stereotactic
surgery.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism version 5.0b
(GraphPad). All data were derived from at least three independent experi-
ments. Asterisks mark experimental groups that were significantly different
from control groups by a two-tailed Students t test, or by ANOVA followed
by Dunnett test to compare control against multiple independent treatment
groups. Data are presented as mean ± SEM unless indicated otherwise.
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The GEO accession number for the microarray gene expression data reported
in this paper is GSE51533.
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